The most commonly marketed sleep cannabinoid has never been shown to promote sleep in a single controlled human trial — the entire "sleepy cannabinoid" reputation rests on cannabis folklore, not science.
Consumers considering CBN sleep products, healthcare providers advising patients, and anyone curious about whether the cannabis industry's sleep claims are evidence-based.
0 sleep trialsThe number of randomized controlled trials testing CBN for sleep identified in the medical literature
The Backstory
Walk into any cannabis dispensary in America and ask for something to help you sleep. Within sixty seconds, someone will hand you a product containing CBN — cannabinol — and tell you it's "the sleepy cannabinoid." The gummies come in purple packaging. The tinctures promise deep, restorative rest. The price point is premium. The marketing is confident.
The evidence? Jamie Corroon went looking for it. He screened 99 human studies. He found eight that met basic inclusion criteria. Not a single one demonstrated that CBN, on its own, reliably produces sedation or improves sleep.
A multi-million dollar product category, built on essentially nothing.
What Corroon Actually Did
Published in Cannabis and Cannabinoid Research in 2021, this review asked a question so basic it's almost embarrassing that it needed asking: is there any clinical evidence that CBN promotes sleep?
Corroon searched PubMed/MEDLINE for every human study involving cannabinol. He found 242 results total, 99 involving human subjects. From those, he identified eight that actually administered CBN to people and measured either sleep-related outcomes or THC-like subjective effects (since CBN is a THC degradation product, the question of whether it produces cannabis-like effects is directly relevant).
0
randomized controlled trials of CBN for sleep identified in the medical literature as of 2021. Zero. The most commonly marketed sleep cannabinoid has never been tested in a proper sleep trial.
By comparison, CBD has been tested in multiple sleep-related trials, and THC's effects on sleep architecture have been studied in dozens of controlled experiments. CBN has been tested in none.
Corroon (2021), Cannabis Cannabinoid Res
What the Eight Studies Found
The studies span from 1973 to 1987 — none are recent. Here's what each found when CBN was given to humans:
The Complete Human Evidence for CBN
Eight Studies, Five Decades Ago, No Sleep Signal
15
Hollister (1973)
Oral CBN 20-400mg: no THC-like mental or physical effects at any dose
6
Perez-Reyes (1973)
IV CBN: required massive doses for any effect — 'orders of magnitude larger than THC'
5
Karniol (1975)
Drowsiness reported with THC but NOT with CBN. CBN alone did not differ from placebo.
15
Hollister & Gillespie (1975)
THC+CBN produced no different effects than THC+placebo
161
Bird (1980)
The largest study: 'no suggestion of systemic effects involving CBN, either alone or in combination'
12
Agurell (1981)
CBN co-administered with THC showed no drug-drug interaction
59
Gong (1984)
CBN at 100, 600, and 1200mg: no dose-related effects. Only THC produced a 'high.'
6
Johansson (1987)
IV and inhaled CBN: 'no psychoactive effects noted' by either route
Corroon (2021), Cannabis Cannabinoid Res
Read that list carefully. The largest study (Bird 1980, 161 participants) found nothing. The study that tested the highest doses (Gong 1984, up to 1,200 mg) found nothing. The study that specifically looked at drowsiness as an outcome (Karniol 1975) found it with THC but not CBN. And the study with the most sensitive route of administration (Johansson 1987, intravenous) found no psychoactive effects at all.
Not a single one of these studies used a validated sleep questionnaire. Not one used polysomnography. The entire clinical evidence base for "the sleepy cannabinoid" amounts to: we gave CBN to people in various ways, and they mostly didn't feel anything.
Where the Myth Came From
The origin of CBN's sleep reputation is a textbook case of how cannabis folklore becomes marketing copy.
CBN doesn't come from the cannabis plant directly. It's what THC turns into when exposed to light, oxygen, and heat over time. Old cannabis — cannabis that's been sitting in a drawer for months — has more CBN and less THC than fresh cannabis. And old cannabis has a reputation for making people sleepy.
But here's the logical error: just because old cannabis is sleepy doesn't mean CBN is the reason. Old cannabis has also lost volatile terpenes (many of which are stimulating), has degraded terpene profiles that favor sedating compounds like myrcene, and has lower overall THC content. The sleepiness could come from any of these changes — or from the simple fact that degraded, less potent cannabis produces a milder, more body-heavy effect than fresh, high-THC flower.
The myth appears to have solidified around a single data point from the Karniol 1975 study — specifically, the finding that CBN combined with THC produced more drowsiness than THC alone. But this was in five subjects, four of whom were psychiatric facility residents likely taking other medications, and CBN alone did not produce drowsiness. One questionable observation in five people became "CBN is the sleepy cannabinoid" on thousands of product labels.
Somewhere along the way, marketing departments added escalating claims. Corroon found manufacturers stating that "CBN's sedative properties are up to 10 times stronger than prescription sleeping drugs." There is no study — in humans, in animals, in cell cultures — that supports this claim. It appears to have been fabricated entirely.
What CBN Actually Is, Pharmacologically
CBN is a partial agonist at the CB1 receptor — the same receptor THC activates — but with considerably lower binding affinity. In theory, this means CBN could produce mild, THC-like effects at sufficient doses. In practice, the doses required appear to be so large that they're impractical. Perez-Reyes' 1973 study found that intravenous CBN required doses "several orders of magnitude larger than those of delta-9-THC" to produce any cannabis-like effect.
Some preclinical (animal) studies have shown CBN prolonging barbiturate-induced sleep in mice — but this is a drug-drug interaction, not standalone sedation, and mouse models of sleep don't translate cleanly to humans. Other animal studies found no sedative effect at all.
The honest pharmacological summary: CBN is a weak cannabinoid that might produce mild effects at very high doses, has never been shown to promote sleep in a controlled human trial, and has no mechanism of action that would predict it to be a particularly effective sedative compared to THC, CBD, or dozens of other compounds.
The Industry Problem
This review matters beyond the pharmacology because it illuminates a structural problem in the cannabis industry.
Cannabis products are marketed as supplements and wellness products, not drugs. They don't require FDA approval, clinical trials, or evidence of efficacy before going to market. A manufacturer can put CBN in a gummy, label it as a sleep aid, price it at a premium, and sell millions of units without ever demonstrating that CBN does anything for sleep. The regulatory framework allows it. Consumer trust fills in the rest.
Corroon's conclusion was blunt: "Individuals seeking cannabis-derived sleep aids should be skeptical of manufacturers' claims of sleep-promoting effects."
This isn't unique to CBN — the cannabis industry regularly outpaces its evidence base. But CBN is perhaps the most egregious example: a product category worth hundreds of millions of dollars, built on a myth traceable to a five-person study from 1975 that didn't even support the claim being made.
Key Takeaways
Cannabinol and Sleep: Separating Fact from Fiction
Corroon J (2021) · Cannabis and Cannabinoid Research
Should I stop buying CBN products for sleep?
If a CBN product helps you sleep, the benefit is likely coming from other ingredients (THC, CBD, terpenes like myrcene or linalool) or from placebo effect — not from CBN itself. There's nothing harmful about CBN, but you may be paying a premium for an ingredient that isn't doing what the label claims. A product with the same other ingredients minus the CBN would likely work identically.
Why do so many people say CBN helps them sleep?
CBN products almost always contain other cannabinoids and terpenes that do have sleep-relevant effects. THC reduces sleep onset latency. Myrcene is sedating. CBD reduces anxiety. When someone takes a "CBN gummy" and falls asleep, they're attributing the effect to the highlighted ingredient on the label rather than the full formulation. It's like attributing a multivitamin's effects to one ingredient listed in bold.
Could future research prove CBN helps with sleep?
It's possible but unlikely. The pharmacological profile of CBN — a weak partial CB1 agonist with low binding affinity — doesn't predict strong sedative effects. A well-designed RCT could test it, but given the existing data showing no signal across eight studies and doses up to 1,200mg, the odds of discovering a meaningful sleep effect are low.
Is there any harm in taking CBN?
CBN appears well-tolerated at the doses used in the studies reviewed (up to 1,200mg). At the much lower doses found in commercial products (typically 5-10mg), safety concerns are minimal. The harm is financial and opportunity-based: you're paying for an unproven ingredient, and you might delay finding approaches that actually work.
What the researchers found
A systematic search of PubMed found zero randomized controlled trials of CBN for sleep. Eight human studies (1973-1987) administered CBN to people; none found reliable sedative or cannabis-like effects from CBN alone. The largest study (161 participants) reported no systemic effects. The marketing claim that CBN is a powerful sleep aid has no clinical evidence supporting it.
Why it matters
CBN is marketed aggressively as "the sleepy cannabinoid" and commands premium prices in dispensaries. This review revealed that the entire clinical evidence base consists of eight old studies, none of which support the sleep claim. It exposes a structural problem where cannabis products can be marketed as sleep aids without clinical proof.
The numbers in context
- 99 human studies screened
- 8 met inclusion criteria for detailed review
- 0 used validated sleep questionnaires or polysomnography
- 0 RCTs of CBN for sleep exist
- Doses up to 1,200mg tested with no dose-related effects (Gong 1984)
- 161 participants in largest study showed no CBN effects (Bird 1980)
How the study worked
Narrative review searching PubMed/MEDLINE with MeSH terms for cannabinol (242 results total, 99 in humans). Eight studies met inclusion criteria: administration of CBN to humans with measurement of sleep-related or cannabis-like subjective effects. Studies reviewed ranged from 1973 to 1987.
Who was studied
99 human studies screened; 8 reviewed in detail involving healthy adult volunteers, predominantly male, 1973-1987
What this study cannot tell us
Narrative review, not a systematic review with formal risk-of-bias assessment. PubMed only (no other databases). Single author. Author is medical director of a for-profit cannabis education center. Included studies were all decades old with small samples. Cannot prove CBN does not work — only that current evidence does not support the claim.
How to read the evidence
Rated moderate: a thorough literature search by a qualified researcher, but single-author narrative review with PubMed-only search. The conclusion is well-supported by the reviewed studies but limited by the age and quality of the underlying evidence base.
When this study was published
Published in 2021, but the 8 included studies date from 1973-1987. No modern clinical trials of CBN for sleep have been published since.
The bigger picture
CBN products represent a broader pattern in the cannabis industry: marketing claims outpacing scientific evidence, enabled by a regulatory framework that doesn't require proof of efficacy. The CBN sleep myth likely originated from the observation that old cannabis (which converts THC to CBN over time) produces sleepiness — but the sleepiness is more plausibly explained by terpene degradation and reduced THC content. This review serves as a consumer protection document as much as a scientific one.
Funding
No funding received for this article.
Conflicts of interest
Author is medical director at the Center for Medical Cannabis Education, a for-profit clinical and consulting entity.
Questions still open
- Could a well-designed RCT find a sleep effect for CBN at doses found in commercial products (5-10mg)?
- What specific terpene and cannabinoid profiles in CBN products account for reported sleep benefits?
- How much of the CBN sleep market is driven by placebo response vs actual pharmacological activity from non-CBN ingredients?
Common questions
Does CBN help you sleep?
Why is CBN called the sleepy cannabinoid?
Are CBN sleep products harmful?
Read the original research
Cannabinol and Sleep: Separating Fact from Fiction
Cannabis and Cannabinoid Research, 6(5), 366-371
Cannabis and Cannabinoid Research is a peer-reviewed journal publishing original research on the science and clinical applications of cannabis.
Citation
Corroon, Jamie. (2021). Cannabinol and Sleep: Separating Fact from Fiction. Cannabis and Cannabinoid Research, 6(5), 366-371. https://doi.org/10.1089/can.2021.0006
Explore the wider topic
- CBD for Sleep: Does It Actually Work?
- Cannabis and Sleep: Does It Actually Help or Just Mask the Problem?
- Why Does Weed Make You Sleepy? THC and Your Sleep-Wake Cycle
- Why Does Weed Make Some People Energetic and Others Sleepy
- How to Store Weed So It Stays Fresh: Temperature, Light, and Humidity
- Does Weed Expire? Shelf Life, Potency Loss, and Storage Science